CIS-DIAMMINEDICHLOROPLATINUM (II) MODIFIED DNA STIMULATES FOR GREATER LEVELS OF S1 NUCLEASE SENSITIVE REGIONS THAN DOES THE MODIFICATION PRODUCED BY THE TRANS-ISOMERSCOVELL WM; CAPPONI VJ.1982; BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS; ISSN 0006-291X; USA; DA. 1982; VOL. 107; NO 3; PP. 1138-1143; BIBL. 21 REF.Article

CURE OF MICE INFECTED WITH TRYPANOSOMA RHODESIENSE BY CIS-DIAMMINEDICHLOROPLATINUM(II) AND DISULFIRAM RESCUEWYSOR MS; ZWELLING LA; SANDERS JE et al.1982; SCIENCE; ISSN 0036-8075; USA; DA. 1982; VOL. 217; NO 4558; PP. 454-456; BIBL. 9 REF.Article

MALLORY-WEISS SYNDROME SECONDARY TO CIS-PLATINUM CHEMOTHERAPY: AN UNUSUAL COMPLICATIONLUBICZ S; SHAFIR M; DIAMOND S et al.1982; J. SURG. ONCOL.; ISSN 0022-4790; USA; DA. 1982; VOL. 20; NO 4; PP. 247-249; BIBL. 32 REF.Article

SYNERGISTIC EFFECT OF RICIN IN COMBINATION WITH DAUNORUBICIN, CIS-DICHLORODIAMMINEPLATINUM (II) A,D VINCRISTINE IN SYSTEMIC L 1210 LEUKEMIAFODSTAD O; PIHL A.1982; CANCER RES.; ISSN 0008-5472; USA; DA. 1982; VOL. 42; NO 6; PP. 2152-2158; BIBL. 22 REF.Article

NEPHROTOXIC POTENTIAL OF CIS-DIAMMINEDICHLOROPLATINUM AND FOUR ANALOGS IN MALE FISCHER 344 RATSLEVINE BS; HENRY MC; PORT CD et al.1981; J. NATL. CANCER INST.; ISSN 0027-8874; USA; DA. 1981; VOL. 67; NO 1; PP. 201-206; BIBL. 21 REF.Article

ANTIBODIES ELICITED AGAINST CIS-DIAMMINEDICHLOROPLATINUM(II)-MODIFIED DNA ARE SPECIFIC FOR CIS-DIAMMINEDICHLORO-PLATINUM(II)-DNA ADDUCTS FORMED IN VIVO AND IN VITROPOIRIER MC; LIPPARD SJ; ZWELLING LA et al.1982; PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. BIOLOGICAL SCIENCES; ISSN 0273-1134; USA; DA. 1982; VOL. 79; NO 21; PP. 6443-6447; BIBL. 23 REF.Article

RENAL EXCRETION OF MAGNESIUM AND TRACE ELEMENTS DURING CISPLATIN TREATMENTZUMKLEY H; BERTRAM HP; PREUSSER P et al.1982; CLIN. NEPHROL.; ISSN 0301-0430; DEU; DA. 1982; VOL. 17; NO 5; PP. 254-257; BIBL. 12 REF.Article

EVALUATION D'UN NOUVEL ANTI-EMETIQUE, L'ALIZAPRIDE, EN CANCEROLOGIECUPISSOL D; FAVIER F; FAVIER C et al.1982; SEMAINE DES HOPITAUX; ISSN 0037-1777; FRA; DA. 1982; VOL. 58; NO 22; PP. 1370-1373; ABS. ENG; BIBL. 12 REF.Article

CISPLATYLJACQUILLAT C; KHAYAT D.1982; MED. INTERNE; ISSN 0025-6781; FRA; DA. 1982; NO 6-7; PP. 241-244Article

ESSAI D'EFFICACITE THERAPEUTIQUE DU CIS-DIAMINO-DICHLORO-PLATINUM EN INSTILLATION LOCALE SUR LES TUMEURS VESICALES RECIDIVANTES EN PLACETOULOUSE J; ROSENBAUM A; ETIEVENT JP et al.1982; J. UROL.; ISSN 0248-0018; FRA; DA. 1982; VOL. 88; NO 2; PP. 105-109; ABS. ENG; BIBL. 8 REF.Article

SOME OBSERVATIONS ON THE MECHANISM OF BLOCKING OF NUCLEAR STAINING BY CISPLATINSUMNER AT.1982; HISTOCHEM. J.; ISSN 0018-2214; GBR; DA. 1982; VOL. 14; NO 2; PP. 283-299; BIBL. 2 P.Article

RAPID ONSET HEARING LOSS AFTER CISPLATINUM THERAPY: CASE REPORTS AND LITERATURE REVIEWCHAPMAN P.1982; J. LARYNGOL. OTOL.; ISSN 0022-2151; GBR; DA. 1982; VOL. 96; NO 2; PP. 159-162; BIBL. 14 REF.Article

CIS-DIAMMINEDICHLOROPLATINUM(II) MODIFICATION OF SV40 DNA OCCURS PREFERENTIALLY IN (G+C) RICH REGIONS: IMPLICATIONS INTO THE MECHANISM OF ACTIONSCOVELL WM; KROOS LR.1982; BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS; ISSN 0006-291X; USA; DA. 1982; VOL. 108; NO 1; PP. 16-23; BIBL. 23 REF.Article

CLINICAL PHARMACOLOGY OF BLEOMYCIN AND CISPLATINEVANS WE; YEE GC; CROM WR et al.1982; DRUG INTELL. CLIN. PHARM.; ISSN 0012-6578; USA; DA. 1982; VOL. 16; NO 6; PP. 448-458; BIBL. 118 REF.Article

ETUDE PHARMACOCCINETIQUE DU PLATINE TOTAL CHEZ DES ENFANTS ET DES ADULTES APRES ADMINISTRATION DU CIS-DICHLORODIAMMINE-PLATINUM (II) (CDDP) SELON DIFFERENTS PROTOCOLESBUES CHARBIT M; CANO JP; CATALIN J et al.1982; JOURNAL DE PHARMACIE CLINIQUE; ISSN 0291-1981; FRA; DA. 1982; VOL. 1; NO 2; PP. 187-201; ABS. ENG; BIBL. 16 REF.Article

HAEMOLYTIC ANAEMIA AFTER CISPLATIN TREATMENTLEVI JA; ARONEY RS; DALLEY DN et al.1981; BR. MED. J.; ISSN 0007-1447; GBR; DA. 1981; VOL. 282; NO 6281; PP. 2003-2004; BIBL. 5 REF.Article

STABILITY OF CISPLATIN IN AQUEOUS SOLUTIONGREENE RF; CHATTERJI DC; HIRANAKA PK et al.1979; AMER. J. HOSP. PHARM.; USA; DA. 1979; VOL. 36; NO 1; PP. 38-43; BIBL. 9 REF.Article

ANALYSIS OF TOTAL PLATINUM IN TISSUE SAMPLES BY FLAMELESS ATOMIC ABSORPTION SPECTROPHOTOMETRY ELIMINATION OF THE NEED FOR SAMPLE DIGESTIONPRIESNER D; STERNSON LA; REPTA AJ et al.1981; ANAL. LETT.; ISSN 0003-2719; USA; DA. 1981; VOL. 14; NO 5; PP. 1255-1268; BIBL. 9 REF.Article

CIS-PLATINUM IN GYNECOLOGIC CANCER. III: TOXICITYHALL DJ; DIASIO R; GOPLERUD DR et al.1981; AM. J. OBSTET. GYNECOL.; ISSN 0002-9378; USA; DA. 1981; VOL. 141; NO 3; PP. 309-312; BIBL. 21 REF.Article

KINETICS OF THE REACTION OF CIS-PT(NH₃)₂CL₂ WITH DNAS OF DIFFERENT G-C CONTENTJOHNSON NP; BUTOUR JL.1981; J. AM. CHEM. SOC.; ISSN 0002-7863; USA; DA. 1981; VOL. 103; NO 24; PP. 7351-7352; BIBL. 19 REF.Article

DROGAS ANTINEOPLASICAS = MEDICAMENT ANTICANCEREUXESTEVEZ ROBERTO A ED; ALVAREZ CARLOS A ED.1980; ; ARG; BUENOS AIRES: UNIVERSIDAD DEL SALVADOR; DA. 1980; 152 P.; 23 CM; BIBL. 15 REF.Book

THE MECHANISM OF RENAL CLEARANCE OF CISPLATIN (CIS-DICHLORODIAMMINE PLATINUM II) AND ITS MODIFICATION BY FUROSEMIDE AND PROBENECIDDALEY YATES PT; MCBRIEN DCH.1982; BIOCHEM. PHARMACOL.; ISSN 0006-2952; GBR; DA. 1982; VOL. 31; NO 13; PP. 2243-2246; BIBL. 20 REF.Article

CIPROPRIDE IN PREVENTING NAUSEA AND VOMITING INDUCED BY SEVERELY EMETIC CYTOSTATIC AGENTSSERROW B; CUPISSOL D; ROSENFELD C et al.1981; J. INT. MED. RES.; ISSN 0300-0605; GBR; DA. 1981; VOL. 9; NO 5; PP. 390-391; BIBL. 3 REF.Article

INHIBITION OF THE BAM HI CLEAVAGE AND UNWINDING OF PBR322 DEOXYRIBONUCLEIC ACID BY THE ANTITUMOR DRUG CIS-DICHLORODIAMMINEPLATINUM(II)USHAY HM; TULLIUS TD; LIPPARD SJ et al.1981; BIOCHEMISTRY (EAST.); ISSN 0006-2960; USA; DA. 1981; VOL. 20; NO 13; PP. 3744-3748; BIBL. 27 REF.Article

TREATMENT OF DIFFUSE PLEURAL MALIGNANT MESOTHELIOMA BY CIS DICHLORO DIAMINE PLATINUM (C. D. D. P.) IN NINE PATIENTSDABOUIS G; LE MEVEL B; CORROLLER J et al.1981; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1981; VOL. 5; NO 3; PP. 209-210; BIBL. 10 REF.Article